Underwhelming pah data. Significant drop-out rate in primary trial. 25% drop-out going into extension study. Only 12.5% of the small subject number achieved high dose. Failed on crucial 6MWT. No evaluation of drug to placebo, only compared drug to it's own baseline and only compared placebo to it's own baseline. Treatment arm had healthier and younger subjects than placebo arm. Results appear to be false positive.
How long can a company buy their own stock each day spending $250,000 each day?
From their recent 10-Q Company filing regarding Lawsuits:- A panel of the Ninth Circuit heard oral argument on the appeal on May 4, 2016. On October 26, 2016, the Ninth Circuit panel reversed the District Court’s dismissal of the second consolidated amended complaint and remanded the case back to the District Court for further proceedings. On January 25, 2017, the District Court permitted us to submit a renewed motion to dismiss the second consolidated amended complaint. On February 2, 2017, we filed the renewed motion to dismiss. On February 23, 2017, the lead plaintiff filed his opposition, and on March 2, 2017, we filed our reply. On April 28, 2017, the District Court denied our renewed motion to dismiss. Due to the stage of these proceedings, we are not able to predict or reasonably estimate the ultimate outcome or POSSIBLE LOSES relating to these claims.
Do you think declining sales of only drug helps the bottom line? Got only a poor selling diet pill after 20 years as a company
Longtards see big things cause pps went from $135.0 ( 13.5) to $25.11 ( 2.51) in the longest bull market in history. Sad in a funny way.
Friends, pps propped up thru accounting smoke and mirrors and the 6 IB's that were paid for their services. On Monday Sept 18 55.4% of trades shorted arna. On Tuesday Sept 19 45% of trades went short. This house of cards will come crashing down.
People forget the Class Action Lawsuit is not yet over. The 9th Circuit court decision is due anyday now. The settlement will be in the $$ Millions + Legal costs. Now it makes sense as to why they raised all that cash and also why this is trading higher for funds to get out before the news and PPS crash!
Follow the Big Money Research and development expenses totaled $17.9 million. General and administrative expenses totaled $7.2 million. Net loss was $23.6 million or $0.77 per share. Not A $24 per share company lMO And a wopping lost 83% of instituional investment
Inst Ownership Down Huge over past 3 years. Insiders own just 0.26%....No belief in co or it's products
Just 42.7 million more shares to reach 6/16/17 authorized share number.
ARNA just needs to add 42.7 million more shares to reach their 6/16/17 authorized share number. Will happen sooner not later.
ARNA just stole 22% of anyone holding the stock by diluting. Just posted a $23.6 million loss and had a 83% drop in financial investment leave.... Are there any clues here? Hummm
Accounting tricks like what's happening with this never last. Don't get caught by smoke and mirrors
Cant fund the ancient delayed pipe when sales of only drug are so low and WS expects them to fall 77% again 3Q
More manipulation to keep investors believing but anyone holding this stock for 2 years has it at $20.60 or lower. So this is the best get out point they have No investor will risk this gain sending it lower
Good morning. They are desperately trying to keep it higher. The stock has no buyer except the company. over 83% loss in Institutional investment left. Follow the big money. They got out
I don't know how to reply to conversations so I reply to previous posts with new conversations. I think cluttering MB helps my underwater position. I am a arnatard
If you are looking for novel therapies meeting untreated patient populations you are looking in the WRONG place. This company is 100% about using old technology to apply it to broad market populations.
Record low volume. No excitement about this pos. PPS not tied to weak company or it's old science behind eight ball delayed pipe.